Skip NavigationSkip to Content

Zebularine: A unique molecule for an epigenetically based strategy in cancer chemotherapy. The magic of its chemistry and biology

  1. Author:
    Marquez, V. E.
    Barchi, J. J.
    Kelley, J. A.
    Rao, K. V. R.
    Agbaria, R.
    Ben-Kasus, T.
    Cheng, J. C.
    Yoo, C. B.
    Jones, P. A.
  2. Author Address

    NCI, Ctr Canc Res, Med Chem Lab, NIH, Frederick, MD 21702 USA. Ben Gurion Univ Negev, Dept Clin Pharmacol, Fac Hlth Sci, IL-84105 Beer Sheva, Israel. Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Urol, Los Angeles, CA USA. Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA USA Marquez, VE, NCI, Ctr Canc Res, Med Chem Lab, NIH, Frederick, MD 21702 USA
    1. Year: 2005
  1. Journal: Nucleosides Nucleotides & Nucleic Acids
    1. 24
    2. 5-7, Sp. Iss.
    3. Pages: 305-318
  2. Type of Article: Article
  1. Abstract:

    1-(beta-(D)-ribofuranosyl)- 1,2-dihydropyrimidin-2-one (zebularine) is structurally 4-deamino cytidine. The increased electraphilic character of this simple aglycon endows the molecule with unique chemical and biological properties, making zebularine a versatile starting material for the synthesis of complex nucleosides and an effective inhibitor of cytidine deaminase and DNA cytosine methyltransferase. Zebularine is a stable, antitumor agent that preferentially targets cancer cells and shows activity both in vitro and in experimental animals, even after oral administration

    See More

External Sources

  1. WOS: 000232473500001

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel